ArticleThe journal of headache and pain2022

Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials.

Christian Lampl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.